Morgan Stanley analyst Keith Weiss raised the firm’s price target on Oracle (ORCL) to $175 from $145 and keeps an Equal Weight rating on the shares. . In Oracle’s Q2, the remaining performance obligation figure stepped down from $99B to $97B, which while still up 50% year-over-year in constant currency, suggests bookings declined about 11% year-over-year, the analyst tells investors. With bookings growth turning negative, investor focus shifts back to the income statement, where both Q2 and the Q3 guidance “fell shy of investor expectations,” adds the analyst, who views Oracle shares as likely to remain range bound as investors assess whether bookings momentum can return. The firm raised its target as it rolls forward valuation to calendar year 2026, the analyst noted.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle price target raised to $194 from $157 at Citi
- Oracle price target raised to $210 from $185 at Piper Sandler
- Oracle price target raised to $213 from $202 at Bernstein
- Oracle Reports Strong Q2 Growth with Cloud and AI Focus
- Closing Bell Movers: Oracle slips 8% after Q2 earnings miss, disappointing guide